CMS Proposes "Trial Sizes" Of Prescriptions To Curb Waste Of Unused Drugs In Part D
This article was originally published in The Pink Sheet Daily
Executive Summary
Under a plan outlined in a draft Medicare Part D "call letter," patients receiving a new prescription for a drug previously unused by them would be able to receive an initial trial size supply of no more than seven to 14 days.